Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 652 Jul 26 – Oct 23, 2026
- Disclosed funding
- $24B 453 disclosed amounts
- Median round
- $5.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| H HiBobCompany profile HiBob develops Bob, a cloud people-management platform for growing and multinational companies. HiBob develops Bob, a cloud people-management platform for growing and multinational companies. | $166M | Series FSeries C+ | Enterprise software | United Kingdom | Investors | |
| x xorlabCompany profile xorlab protects organizations from phishing and other email attacks with behavioral AI that detects threats in the context of their communication patterns. xorlab protects organizations from phishing and other email attacks with behavioral AI that detects threats in the context of their communication patterns. | €5M | Series A+Series A | Cybersecurity | Switzerland | Investors | |
| H HolifyaCompany profile Holifya is a digital clinic for obesity and metabolic health that combines physician-supervised care with nutrition and behavioral support. Clinicians assess each patient and may prescribe GLP-1/GIP medicines when medically appropriate; the medication sits within an ongoing programme of personalized eating, activity and follow-up rather than being dispensed as a standalone product. Holifya is a digital clinic for obesity and metabolic health that combines physician-supervised care with nutrition and behavioral support. Clinicians assess each patient and may prescribe GLP-1/GIP medicines when medically appropriate; the medication sits within an ongoing programme of personalized eating, activity and follow-up rather than being dispensed as a standalone product. | €2M | FundingUndisclosed | Healthtech | Italy | Investors | |
| PT PANDA TherapeuticsCompany profile PANDA Therapeutics develops an antibody-based platform targeting protein aggregates involved in Alzheimer’s disease. PANDA Therapeutics develops an antibody-based platform targeting protein aggregates involved in Alzheimer’s disease. | CHF 100K | Venture Kick Stage IIIUndisclosed | Biotech | Switzerland | Investors | |
| E ElektaCompany profile Elekta makes radiation-treatment systems and oncology software for clinical teams treating cancer and selected neurological conditions. Elekta makes radiation-treatment systems and oncology software for clinical teams treating cancer and selected neurological conditions. | ≤€100M | EIB loanUndisclosed | Healthtech | Sweden | Investors | |
FoldcastCompany profile Foldcast designs and fabricates structural concrete elements using digitally optimized designs and recyclable paper-based moulds. Foldcast designs and fabricates structural concrete elements using digitally optimized designs and recyclable paper-based moulds. | CHF 100K | Venture Kick Stage 3 convertible loanPre-seed | Industrial tech | Switzerland | Investors | |
| S S-TransistorsCompany profile Superconducting transistor circuits that let quantum hardware teams route more measurement channels through the limited wiring inside cryogenic refrigerators. Superconducting transistor circuits that let quantum hardware teams route more measurement channels through the limited wiring inside cryogenic refrigerators. | €2.6M | Pre-seed | Hardware | Finland | Investors | |
| N NexeonCompany profile Nexeon develops silicon anode materials for battery manufacturers seeking to store more energy in lithium-ion cells for vehicles, electronics and energy storage. Nexeon develops silicon anode materials for battery manufacturers seeking to store more energy in lithium-ion cells for vehicles, electronics and energy storage. | £100M | Investment roundUndisclosed | Industrial tech | United Kingdom | Investors | |
| H HealfCompany profile Healf is a consumer wellbeing retailer that curates supplements, food, skincare and health technology alongside personalised guidance. Healf is a consumer wellbeing retailer that curates supplements, food, skincare and health technology alongside personalised guidance. | Undisclosed | Minority investmentUndisclosed | Ecommerce | United Kingdom | Investors | |
| KM KOVE MedicalCompany profile KOVE Medical develops an implantable closure device for fetal surgeons, designed to seal the membrane opening left after procedures performed during pregnancy. KOVE Medical develops an implantable closure device for fetal surgeons, designed to seal the membrane opening left after procedures performed during pregnancy. | CHF 1.6M | Angel financing roundUndisclosed | Healthtech | Switzerland | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 26, 2026
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
17rounds0led - 2Innovate UK
Emerald, Go Eve, Affinity Labs
14rounds0led - 3High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
12rounds4led - 4Bpifrance
Nouscom, CarbonFarm, Edonia
11rounds0led - 5NVIDIA
Riverlane, Foresight, Hiverge
11rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.